News Home Page
Access the 15 most recent news items below. For older items, please click the 'view archives' link in the lower right.
Pitt-Developed Test Holds Potential to Diagnose Myriad Conditions with Drop of Blood
Researchers at the University of Pittsburgh have developed a unique method for detecting antibodies in the blood of patients in a proof-of-principle study that opens the door to development of simple diagnostic tests for diseases for which no microbial cause is known, including auto-immune diseases, cancers and other conditions.The results, reported in the Journal of Immunological Methods and funded by the Bill & Melinda Gates Foundation, are the first evidence that it is possible to develop blood ...
Posted on: July 25, 2016
Beckman Coulter and Ortho Clinical Diagnostics Aim to Deliver Infectious Disease Testing Menu
Beckman Coulter, Inc., a global developer and manufacturer of clinical diagnostic products, and Ortho Clinical Diagnostics (Ortho), a global in vitro diagnostics leader, recently announced a strategic relationship regarding sales of Ortho's VITROS 3600 Immunodiagnostic System and infectious disease menu in the U.S.Ortho's VITROS 3600 System offers a broad menu of infectious disease tests that are used by several of the leading reference laboratories in the United States. It combines three ...
Posted on: July 24, 2016
Phenomenex Awards Professor for HIV Treatment Breakthrough
Phenomenex, Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, along with The Analytical Scientist, a leading industry publication, is pleased to present the 2016 Humanity in Science Award to Waseem Asghar, assistant professor at Florida Atlantic University, for developing an innovative and cost-effective paper and flexible material-based diagnostic method of biosensing that can be used to detect and determine treatment options for HIV, E. ...
Posted on: July 23, 2016
Great Basin Begins Clinical Trial for Stool Bacterial Pathogens Panel
Great Basin Scientific, Inc. (NASDAQ: GBSN), a molecular diagnostics company, announced recently that it has initiated a clinical trial for its Stool Bacterial Pathogens Panel, a multiplex molecular assay detecting common bacterial agents, including foodborne pathogens, present in individuals suspected of acute gastroenteritis. The Stool Bacterial Pathogens Panel is the Company's second multiplex panel.The Stool Bacterial Pathogens Panel will target nucleic acids of Salmonella species, Shigella species, ...
Posted on: July 22, 2016
Cyrex Provides Accurate Assessment and Monitoring of Intestinal Barrier Function
Cyrex Laboratories, a clinical laboratory specializing in functional immunology and autoimmunity, offers Array 2, an intestinal antigenic permeability screen. The Array 2 is the most advanced test on the market to accurately measure intestinal permeability or "leaky gut" as well as assess systemic Lipopolysaccharides (LPS)-a byproduct of bacteria. The Array 2 is unique among clinical testing in its ability to identify the route of damage occurring in the intestinal barrier. Knowing the pathway of ...
Posted on: July 21, 2016
Calgary Scientific Shares Findings from Healthcare Providers' Roundtable on Mobile Adoption Strategies and Policies
Calgary Scientific Inc., a company known for creating innovative technology for the medical industry and beyond, announced results of a roundtable about mobile adoption strategies and policies by healthcare providers. To learn more about the current state of mobile adoption for clinical care, Calgary Scientific convened a virtual roundtable of industry experts and clinical leadership from Martin Luther King Junior Community Hospital, Center for Connected Health Policy, SUNY Downstate School of Medicine, ...
Posted on: July 20, 2016
Genetic Code of Red Blood Cells Discovered
Eight days. That's how long it takes for skin cells to reprogram into red blood cells. Researchers at Lund University in Sweden, together with colleagues at Center of Regenerative Medicine in Barcelona, have successfully identified the four genetic keys that unlock the genetic code of skin cells and reprogram them to start producing red blood cells instead."We have performed this experiment on mice, and the preliminary results indicate that it is also possible to reprogram skin cells from humans into red ...
Posted on: July 19, 2016
Clinical Genomics Announces Implementation of UNIConnect
Clinical Genomics, a private company developing advanced diagnostic tools for colorectal cancer, today announced that it has signed an agreement with UNIConnect LC to implement the company's Precision Molecular Diagnostics (pMDx) laboratory information management system (LIMS) in its two laboratories. The software system will facilitate comprehensive automation of all laboratory processes from sample accessioning through final clinical result reporting.Following an extensive evaluation period, Clinical ...
Posted on: July 18, 2016
Laboratorians are Uniquely Positioned to Help Reduce Adverse Patient Outcomes
COLA, a national laboratory accreditor and advocate for quality in laboratory medicine and patient care, has recognized the findings of a Johns Hopkins study that concludes that if medical errors were tabulated similarly to diseases, they would rank as the third leading cause of death in the U.S. (with more than 250,000 deaths each year), behind only heart disease and cancer. The accreditor calls on the medical community to begin addressing the concerns raised by the study, while issuing a series of ...
Posted on: July 17, 2016
Superbug Scare: GVSU Faculty Searching for Solutions to Antibiotic Resistance
For the first time appearing in the U.S., a rare type of E. coli infection that scientists are calling a "superbug" was found last week in a 49-year-old Pennsylvania woman. This "superbug" is resistant to many antibiotics, even Colistin, which doctors use as a last resort when other antibiotics aren't effective.Researchers said if the gene that made the E. coli drug-resistant, called mcr-1, passes to another superbug with other mutations, it could result in bacteria that resists all known antibiotics.At ...
Posted on: July 16, 2016
Horizon and Ubiquigent Enter into Collaboration Agreement
Horizon Discovery Group (LSE: HZD) ("Horizon"), a world leader in the application of gene editing technologies, including cell models, recently announced it has entered into a Collaboration Agreement with Ubiquigent Ltd ("Ubiquigent"). Under the terms of the agreement, Ubiquigent will be able to utilize Horizon's X-MAN cell lines as part of its ubiquitin system focused Drug Discovery Services.The ubiquitin system offers many new drug discovery target opportunities across multiple therapeutic areas ...
Posted on: July 15, 2016
AMGA Announces MACRA and Risk Initiative
AMGA recently launched its MACRA and Risk Initiative to help its members prepare for and succeed under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) and in all risk-based payment systems. MACRA changes Medicare's physician financing model in the most significant and far-reaching way since the program's inception in 1965. It repeals the Sustainable Growth Rate (SGR) formula, and presents two pathways for taking on risk in the Medicare program: a new Merit-Based Incentive Payment System ...
Posted on: July 14, 2016
Anemia Negatively Affects Recovery from Traumatic Brain Injuries
Approximately half of patients hospitalized with traumatic brain injuries are anemic, according to recent studies, but anemia's effects on the recovery of these patients is not clear. Now, researchers from the University of Missouri School of Medicine have found evidence that anemia can negatively influence the outcomes of patients with traumatic brain injuries."More research is needed to develop treatment protocols for anemic patients with traumatic brain injuries," said N. Scott Litofsky, MD, chief of ...
Posted on: July 13, 2016
bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® BRAHMS PCT Test for Managing Sepsis
bioMérieux, a world leader in the field of in vitro diagnostics, recently announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of the VIDAS BRAHMS PCT (Procalcitonin) assay using the change in PCT levels over time to aid in the management of sepsis patients after the initial diagnosis. Based on a recent study, monitoring PCT levels over four days (96 hours) can help doctors determine which septic patients are at the greatest risk of death, ...
Posted on: July 12, 2016
Empirical Bioscience's TAQ DNA Polymerase Labeling Includes Long Term Refrigeration and Temperature Storage
Empirical Bioscience announced recently that their Taq DNA Polymerase is now labeled for storage at room temperature (15 °to 25°C) for up to 30 days and for refrigeration at 4°C for up to 90 days.This product improvement is the result of ongoing optimization work at Empirical Bioscience's new manufacturing facility in Grand Rapids, Michigan. Tests conducted by the company show that their TAQ DNA Polymerase, a recombinant Taq, exhibits no detectable loss of function when stored and used under these ...
Posted on: July 12, 2016